Farmak AS - Company Review
Farmak AS - Company ReviewSummary
Farmak AS (Farmak) is a chemical and pharmaceutical company that develops, produces and commercializes generic active pharmaceutical ingredients. The company offers active pharmaceuticals ingredients such as zileuton, brimonidine tartrate, nepafenac, moxonidine, butamirate citrate, tizanidine hydrochloride, zopiclone and riluzole. Its special products and intermediates include 4-bromophenyl methyl sulfide, 4- hydroxycoumarin and tetra – o – benzyl – d – glucopyranose among others. The company’s expertise spans in the production of organic substances for pharmaceutical purpose. It focuses mainly on chemical research and development of chemical procedures. The company exports its products to Europe, America and Asia. Farmak is headquartered in Olomouc, Czech Republic.
This comprehensive company report of Farmak AS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.